Related Experiment Video
Updated: May 9, 2026
07:10
In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
Spatiotemporal analysis reveals distinct inflammatory programs underlying chronic colitis
Jennifer Fransson1, Chiara Sorini1, Francisca Castillo1
1Division of Immunology and Respiratory Medicine, Department of Medicine Solna, Karolinska Institute and University Hospital, 171 76, Stockholm, Sweden; Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden; Center of Molecular Medicine, Karolinska University Hospital, 171 64, Solna, Sweden.
Immunity
|May 7, 2026
Summary
This study reveals conserved inflammatory pathways in Inflammatory Bowel Disease (IBD) using advanced transcriptomic analysis in mouse models. Findings highlight neutrophil-associated inflammation and cytokine signaling as key targets for future IBD therapies.
Area of Science:
- Gastroenterology and Immunology
- Molecular Biology and Genetics
Background:
- Inflammatory Bowel Disease (IBD) presents a significant clinical challenge due to resistance to conventional immunomodulatory treatments.
- Understanding the complex interplay between immune, epithelial, and stromal cells during IBD pathogenesis is crucial for developing effective therapies.
Purpose of the Study:
- To elucidate the cellular and molecular mechanisms underlying IBD initiation and progression.
- To identify conserved inflammatory pathways and spatial heterogeneity in disease models and human IBD datasets.
- To create a high-resolution spatiotemporal atlas to guide therapeutic strategies for IBD.
Main Methods:
- Utilized T cell transfer and Il10-deficient spontaneous colitis mouse models.
- Integrated bulk, single-cell, and spatial transcriptomic analyses over time.
- Compared murine transcriptional data with human IBD patient datasets.
Main Results:
- Mouse models recapitulated key features of chronic inflammation, including neutrophil infiltration and impaired tissue regeneration.
- Neutrophil-associated inflammation and cytokine signaling were identified as conserved pathways across species.
- Discovered spatial heterogeneity in inflammatory modules and three distinct gene programs with differential distributions, including tertiary lymphoid structures.
Conclusions:
- The integrated spatiotemporal atlas provides a comprehensive view of IBD pathogenesis.
- Conserved pathways offer promising targets for novel immunomodulatory treatments in IBD.
- These findings will facilitate the optimization of therapeutic strategies for patients with Inflammatory Bowel Disease.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...